{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:17:23Z","timestamp":1790223443809,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T00:00:00Z","timestamp":1476921600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T00:00:00Z","timestamp":1476921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R21CA178424"],"award-info":[{"award-number":["R21CA178424"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["Intramural Research Program"],"award-info":[{"award-number":["Intramural Research Program"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","award":["Translational research Grant"],"award-info":[{"award-number":["Translational research Grant"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K23-AR68433"],"award-info":[{"award-number":["K23-AR68433"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K08-AR065577-03"],"award-info":[{"award-number":["K08-AR065577-03"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001946","name":"American Skin Association","doi-asserted-by":"publisher","award":["Research Grant"],"award-info":[{"award-number":["Research Grant"]}],"id":[{"id":"10.13039\/100001946","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s00403-016-1698-8","type":"journal-article","created":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T09:26:30Z","timestamp":1476955590000},"page":"11-19","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["CD164 identifies CD4+ T cells highly expressing genes associated with malignancy in S\u00e9zary syndrome: the S\u00e9zary signature genes, FCRL3, Tox, and miR-214"],"prefix":"10.1007","volume":"309","author":[{"given":"Bernice M.","family":"Benoit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Jariwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Landon K.","family":"Oetjen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne","family":"Werth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea B.","family":"Troxel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Sicard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel W.","family":"McVicar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain H.","family":"Rook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3648-8429","authenticated-orcid":false,"given":"Maria","family":"Wysocka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,20]]},"reference":[{"key":"1698_CR1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/intimm\/dxh219","volume":"17","author":"B Agrawal","year":"2005","unstructured":"Agrawal B, Longenecker BM (2005) MUC1 mucin-mediated regulation of human T cells. Int Immunol 17:391\u2013399. doi: 10.1093\/intimm\/dxh219","journal-title":"Int Immunol"},{"key":"1698_CR2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.coi.2011.12.001","volume":"24","author":"P Aliahmad","year":"2012","unstructured":"Aliahmad P, Seksenyan A, Kaye J (2012) The many roles of TOX in the immune system. Curr Opin Immunol 24:173\u2013177","journal-title":"Curr Opin Immunol"},{"key":"1698_CR3","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1182\/blood-2009-12-256719","volume":"116","author":"E Ballabio","year":"2010","unstructured":"Ballabio E, Mitchell T, van Kester MS, Taylor S, Dunlop HM, Chi J, Tosi I, Vermeer MH, Tramonti D, Saunders NJ et al (2010) MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential. Blood 116:1105\u20131113","journal-title":"Blood"},{"key":"1698_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1182\/blood-2011-09-379156","volume":"120","author":"E Begue","year":"2012","unstructured":"Begue E, Jean-Louis F, Bagot M, Jauliac S, Cayuela JM, Laroche L, Parquet N, Bachelez H, Bensussan A, Courtois G et al (2012) Inducible expression and pathophysiologic functions of T-plastin in cutaneous T-cell lymphoma. Blood 120:143\u2013154","journal-title":"Blood"},{"key":"1698_CR5","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/jid.2010.404","volume":"131","author":"A Bensussan","year":"2011","unstructured":"Bensussan A, Remtoula N, Sivori S, Bagot M, Moretta A, Marie-Cardine A (2011) Expression and function of the natural cytotoxicity receptor NKp46 on circulating malignant CD4+ T lymphocytes of Sezary syndrome patients. J Invest Dermatol 131:969\u2013976","journal-title":"J Invest Dermatol"},{"key":"1698_CR6","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/cup.12490","volume":"42","author":"SE Boonk","year":"2015","unstructured":"Boonk SE, Cetinozman F, Vermeer MH, Jansen PM, Willemze R (2015) Differential expression of TOX by skin-infiltrating T cells in Sezary syndrome and erythrodermic dermatitis. J Cutan Pathol 42:604\u2013609","journal-title":"J Cutan Pathol"},{"key":"1698_CR7","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","volume":"116","author":"JJ Campbell","year":"2010","unstructured":"Campbell JJ, Clark RA, Watanabe R, Kupper TS (2010) Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors. Blood 116:767\u2013771","journal-title":"Blood"},{"key":"1698_CR8","doi-asserted-by":"publisher","first-page":"5778","DOI":"10.4049\/jimmunol.179.9.5778","volume":"179","author":"JS Chung","year":"2007","unstructured":"Chung JS, Dougherty I, Cruz PD Jr, Ariizumi K (2007) Syndecan-4 mediates the coinhibitory function of DC-HIL on T cell activation. J Immunol 179:5778\u20135784","journal-title":"J Immunol"},{"key":"1698_CR9","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1182\/blood-2010-08-302034","volume":"117","author":"JS Chung","year":"2011","unstructured":"Chung JS, Shiue LH, Duvic M, Pandya A, Cruz PD Jr, Ariizumi K (2011) Sezary syndrome cells overexpress syndecan-4 bearing distinct heparan sulfate moieties that suppress T-cell activation by binding DC-HIL and trapping TGF-beta on the cell surface. Blood 117:3382\u20133390","journal-title":"Blood"},{"key":"1698_CR10","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.1182\/blood-2010-12-324004","volume":"117","author":"E Coustan-Smith","year":"2011","unstructured":"Coustan-Smith E, Song G, Clark C, Key L, Liu P, Mehrpooya M, Stow P, Su X, Shurtleff S, Pui CH et al (2011) New markers for minimal residual disease detection in acute lymphoblastic leukemia. Blood 117:6267\u20136276","journal-title":"Blood"},{"key":"1698_CR11","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5742","author":"BO Dulmage","year":"2015","unstructured":"Dulmage BO, Akilov O, Vu JR, Falo LD, Geskin LJ (2015) Dysregulation of the TOX-RUNX3 pathway in cutaneous T-cell lymphoma. Oncotarget. doi: 10.18632\/oncotarget.5742","journal-title":"Oncotarget"},{"key":"1698_CR12","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1046\/j.1523-1747.2002.19610.x","volume":"119","author":"K Ferenczi","year":"2002","unstructured":"Ferenczi K, Fuhlbrigge RC, Pinkus J, Pinkus GS, Kupper TS (2002) Increased CCR4 expression in cutaneous T cell lymphoma. J Invest Dermatol 119:1405\u20131410","journal-title":"J Invest Dermatol"},{"key":"1698_CR13","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/j.1600-0560.2012.01883.x","volume":"39","author":"M Goswami","year":"2012","unstructured":"Goswami M, Duvic M, Dougherty A, Ni X (2012) Increased Twist expression in advanced stage of mycosis fungoides and Sezary syndrome. J Cutan Pathol 39:500\u2013507","journal-title":"J Cutan Pathol"},{"key":"1698_CR14","doi-asserted-by":"publisher","first-page":"464","DOI":"10.2340\/00015555-2264","volume":"96","author":"E Guenova","year":"2015","unstructured":"Guenova E, Ignatova D, Chang YT, Contassot E, Mehra T, Saulite I, Navarini AA, Mitev V, Dummer R, Kazakov DV et al (2015) Expression of CD164 on malignant T cells in Sezary syndrome. Acta Derm Venereol 96:464\u2013467","journal-title":"Acta Derm Venereol"},{"key":"1698_CR15","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1158\/1078-0432.CCR-12-3488","volume":"19","author":"E Guenova","year":"2013","unstructured":"Guenova E, Watanabe R, Teague JE, Desimone JA, Jiang Y, Dowlatshahi M, Schlapbach C, Schaekel K, Rook AH, Tawa M et al (2013) TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma. Clin Cancer Res 19:3755\u20133763","journal-title":"Clin Cancer Res"},{"key":"1698_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/1471-2407-6-195","volume":"6","author":"AM Havens","year":"2006","unstructured":"Havens AM, Jung Y, Sun YX, Wang J, Shah RB, Buhring HJ, Pienta KJ, Taichman RS (2006) The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis. BMC Cancer 6:195\u2013207","journal-title":"BMC Cancer"},{"key":"1698_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1476-4598-12-115","volume":"12","author":"AF Huang","year":"2013","unstructured":"Huang AF, Chen MW, Huang SM, Kao CL, Lai HC, Chan JY (2013) CD164 regulates the tumorigenesis of ovarian surface epithelial cells through the SDF-1alpha\/CXCR4 axis. Mol Cancer 12:115\u2013127","journal-title":"Mol Cancer"},{"key":"1698_CR18","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1182\/blood-2014-05-571778","volume":"125","author":"Y Huang","year":"2015","unstructured":"Huang Y, Su MW, Jiang X, Zhou Y (2015) Evidence of an oncogenic role of aberrant TOX activation in cutaneous T-cell lymphoma. Blood 125:1435\u20131443","journal-title":"Blood"},{"key":"1698_CR19","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1182\/blood-2015-02-628149","volume":"126","author":"S Jain","year":"2015","unstructured":"Jain S, Stroopinsky D, Yin L, Rosenblatt J, Alam M, Bhargava P, Clark RA, Kupper TS, Palmer K, Coll MD et al (2015) Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphoma. Blood 126:354\u2013362","journal-title":"Blood"},{"key":"1698_CR20","doi-asserted-by":"publisher","first-page":"990","DOI":"10.4049\/jimmunol.1000793","volume":"185","author":"PT Jindra","year":"2010","unstructured":"Jindra PT, Bagley J, Godwin JG, Iacomini J (2010) Costimulation-dependent expression of microRNA-214 increases the ability of T cells to proliferate by targeting Pten. J Immunol 185:990\u2013997","journal-title":"J Immunol"},{"key":"1698_CR21","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1084\/jem.20021726","volume":"197","author":"L Kari","year":"2003","unstructured":"Kari L, Loboda A, Nebozhyn M, Rook AH, Vonderheid EC, Nichols C, Virok D, Chang C, Horng WH, Johnston J et al (2003) Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma. J Exp Med 197:1477\u20131488","journal-title":"J Exp Med"},{"key":"1698_CR22","doi-asserted-by":"publisher","first-page":"170ra116","DOI":"10.1126\/scitranslmed.3005374","volume":"5","author":"BS Kim","year":"2013","unstructured":"Kim BS, Siracusa MC, Saenz SA, Noti M, Monticelli LA, Sonnenberg GF, Hepworth MR, Van Voorhees AS, Comeau MR, Artis D (2013) TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation. Sci Transl Med 5:170ra116","journal-title":"Sci Transl Med"},{"key":"1698_CR23","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1172\/JCI200524826","volume":"115","author":"EJ Kim","year":"2005","unstructured":"Kim EJ, Hess S, Richardson SK, Newton S, Showe LC, Benoit BM, Ubriani R, Vittorio CC, Junkins-Hopkins JM, Wysocka M et al (2005) Immunopathogenesis and therapy of cutaneous T cell lymphoma. J Clin Invest 115:798\u2013812","journal-title":"J Clin Invest"},{"key":"1698_CR24","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/cyto.a.22095","volume":"81","author":"F Leccia","year":"2012","unstructured":"Leccia F, Nardone A, Corvigno S, Vecchio LD, De Placido S, Salvatore F, Veneziani BM (2012) Cytometric and biochemical characterization of human breast cancer cells reveals heterogeneous myoepithelial phenotypes. Cytometry A 81:960\u2013972","journal-title":"Cytometry A"},{"key":"1698_CR25","doi-asserted-by":"publisher","first-page":"e970025-970021-","DOI":"10.4161\/21624011.2014.970025","volume":"3","author":"IV Litvinov","year":"2014","unstructured":"Litvinov IV, Netchiporouk E, Cordeiro B, Zargham H, Pehr K, Gilbert M, Zhou Y, Moreau L, Woetmann A, Odum N et al (2014) Ectopic expression of embryonic stem cell and other developmental genes in cutaneous T-cell lymphoma. Oncoimmunology 3:e970025-970021-970028","journal-title":"Oncoimmunology"},{"key":"1698_CR26","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1093\/oxfordjournals.jbchem.a022704","volume":"127","author":"T Matsui","year":"2000","unstructured":"Matsui T, Kurosawa N, Hibi K, Akiyama S, Kasai Y, Sakamoto J, Ito K, Nakao A, Muramatsu T (2000) The ratio of splicing variants of MGC-24\/CD164, a sialomucin, correlates with the metastatic potential of colorectal carcinomas. J Biochem 127:1103\u20131107","journal-title":"J Biochem"},{"key":"1698_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1006\/cimm.1996.0259","volume":"173","author":"WD Merritt","year":"1996","unstructured":"Merritt WD, Taylor BJ, Der-Minassian V, Reaman GH (1996) Coexpression of GD3 ganglioside with CD45RO in resting and activated human T lymphocytes. Cell Immunol 173:131\u2013148","journal-title":"Cell Immunol"},{"key":"1698_CR28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/jid.2014.356","volume":"135","author":"H Moins-Teisserenc","year":"2015","unstructured":"Moins-Teisserenc H, Daubord M, Clave E, Douay C, Felix J, Marie-Cardine A, Ram-Wolff C, Maki G, Beldjord K, Homyrda L et al (2015) CD158k is a reliable marker for diagnosis of Sezary syndrome and reveals an unprecedented heterogeneity of circulating malignant cells. J Invest Dermatol 135:247\u2013257","journal-title":"J Invest Dermatol"},{"key":"1698_CR29","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00403-014-1501-7","volume":"306","author":"S Morimura","year":"2014","unstructured":"Morimura S, Sugaya M, Suga H, Miyagaki T, Ohmatsu H, Fujita H, Asano Y, Tada Y, Kadono T, Sato S (2014) TOX expression in different subtypes of cutaneous lymphoma. Arch Dermatol Res 306:843\u2013849","journal-title":"Arch Dermatol Res"},{"key":"1698_CR30","first-page":"131","volume":"1","author":"GF Murphy","year":"1988","unstructured":"Murphy GF (1988) Cutaneous T-cell lymphoma. Adv Pathol 1:131\u2013156","journal-title":"Adv Pathol"},{"key":"1698_CR31","doi-asserted-by":"publisher","first-page":"7518","DOI":"10.4049\/jimmunol.0802230","volume":"182","author":"S Nagata","year":"2009","unstructured":"Nagata S, Ise T, Pastan I (2009) Fc receptor-like 3 protein expressed on IL-2 nonresponsive subset of human regulatory T cells. J Immunol 182:7518\u20137526","journal-title":"J Immunol"},{"key":"1698_CR32","doi-asserted-by":"publisher","first-page":"e151","DOI":"10.1038\/cddis.2011.32","volume":"2","author":"MG Narducci","year":"2011","unstructured":"Narducci MG, Arcelli D, Picchio MC, Lazzeri C, Pagani E, Sampogna F, Scala E, Fadda P, Cristofoletti C, Facchiano A et al (2011) MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sezary syndrome. Cell Death Dis 2:e151","journal-title":"Cell Death Dis"},{"key":"1698_CR33","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1182\/blood-2005-07-2813","volume":"107","author":"M Nebozhyn","year":"2006","unstructured":"Nebozhyn M, Loboda A, Kari L, Rook AH, Vonderheid EC, Lessin S, Berger C, Edelson R, Nichols C, Yousef M et al (2006) Quantitative PCR on 5 genes reliably identifies CTCL patients with 5 to 99\u00a0% circulating tumor cells with 90\u00a0% accuracy. Blood 107:3189\u20133196","journal-title":"Blood"},{"key":"1698_CR34","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1200\/JCO.2010.32.0630","volume":"29","author":"EA Olsen","year":"2011","unstructured":"Olsen EA, Whittaker S, Kim YH, Duvic M, Prince HM, Lessin SR, Wood GS, Willemze R, Demierre MF, Pimpinelli N et al (2011) Clinical end points and response criteria in mycosis fungoides and Sezary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. J Clin Oncol 29:2598\u20132607","journal-title":"J Clin Oncol"},{"key":"1698_CR35","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/jid.2014.479","volume":"135","author":"E Penna","year":"2014","unstructured":"Penna E, Orso F, Taverna D (2014) miR-214 as a key hub that controls cancer networks: small player, multiple functions. J Invest Dermatol 135:960\u2013969","journal-title":"J Invest Dermatol"},{"key":"1698_CR36","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1111\/j.0022-202X.2004.22326.x","volume":"122","author":"E Poszepczynska-Guigne","year":"2004","unstructured":"Poszepczynska-Guigne E, Schiavon V, D\u2019Incan M, Echchakir H, Musette P, Ortonne N, Boumsell L, Moretta A, Bensussan A, Bagot M (2004) CD158k\/KIR3DL2 is a new phenotypic marker of Sezary cells: relevance for the diagnosis and follow-up of Sezary syndrome. J Invest Dermatol 122:820\u2013823","journal-title":"J Invest Dermatol"},{"key":"1698_CR37","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.3324\/haematol.2010.026260","volume":"95","author":"E Scala","year":"2010","unstructured":"Scala E, Abeni D, Pomponi D, Narducci MG, Lombardo GA, Mari A, Frontani M, Picchio MC, Pilla MA, Caprini E et al (2010) The role of 9-O-acetylated ganglioside D3 (CD60) and {alpha}4{beta}1 (CD49d) expression in predicting the survival of patients with Sezary syndrome. Haematologica 95:1905\u20131912","journal-title":"Haematologica"},{"key":"1698_CR38","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.4049\/jimmunol.163.7.4073","volume":"163","author":"LC Showe","year":"1999","unstructured":"Showe LC, Fox FE, Williams D, Au K, Niu Z, Rook AH (1999) Depressed IL-12-mediated signal transduction in T cells from patients with Sezary syndrome is associated with the absence of IL-12 receptor beta 2 mRNA and highly reduced levels of STAT4. J Immunol 163:4073\u20134079","journal-title":"J Immunol"},{"key":"1698_CR39","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/j.1365-2230.2005.01904.x","volume":"30","author":"M Sokolowska-Wojdylo","year":"2005","unstructured":"Sokolowska-Wojdylo M, Wenzel J, Gaffal E, Steitz J, Roszkiewicz J, Bieber T, Tuting T (2005) Absence of CD26 expression on skin-homing CLA+ CD4+ T lymphocytes in peripheral blood is a highly sensitive marker for early diagnosis and therapeutic monitoring of patients with Sezary syndrome. Clin Exp Dermatol 30:702\u2013706","journal-title":"Clin Exp Dermatol"},{"key":"1698_CR40","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3109\/07357907.2012.666692","volume":"30","author":"J Tang","year":"2012","unstructured":"Tang J, Zhang L, She X, Zhou G, Yu F, Xiang J, Li G (2012) Inhibiting CD164 expression in colon cancer cell line HCT116 leads to reduced cancer cell proliferation, mobility, and metastasis in vitro and in vivo. Cancer Invest 30:380\u2013389","journal-title":"Cancer Invest"},{"key":"1698_CR41","doi-asserted-by":"publisher","first-page":"5578","DOI":"10.1158\/0008-5472.CAN-04-1253","volume":"64","author":"R van Doorn","year":"2004","unstructured":"van Doorn R, Dijkman R, Vermeer MH, Out-Luiting JJ, van der Raaij-Helmer EM, Willemze R, Tensen CP (2004) Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sezary syndrome identified by gene expression analysis. Cancer Res 64:5578\u2013558642","journal-title":"Cancer Res"},{"key":"1698_CR42","first-page":"3113","volume":"95","author":"SM Watt","year":"2000","unstructured":"Watt SM, Butler LH, Tavian M, Buhring HJ, Rappold I, Simmons PJ, Zannettino AC, Buck D, Fuchs A, Doyonnas R et al (2000) Functionally defined CD164 epitopes are expressed on CD34(+) cells throughout ontogeny but display distinct distribution patterns in adult hematopoietic and nonhematopoietic tissues. Blood 95:3113\u20133124","journal-title":"Blood"},{"key":"1698_CR43","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/jid.2013.279","volume":"134","author":"M Wysocka","year":"2014","unstructured":"Wysocka M, Kossenkov AV, Benoit BM, Troxel AB, Singer E, Schaffer A, Kim B, Dentchev T, Nagata S, Ise T et al (2014) CD164 and FCRL3 are highly expressed on CD4+ CD26- T cells in Sezary syndrome patients. J Invest Dermatol 134:229\u2013236","journal-title":"J Invest Dermatol"},{"key":"1698_CR44","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1182\/blood-2003-04-1044","volume":"102","author":"N Yawalkar","year":"2003","unstructured":"Yawalkar N, Ferenczi K, Jones DA, Yamanaka K, Suh KY, Sadat S, Kupper TS (2003) Profound loss of T-cell receptor repertoire complexity in cutaneous T-cell lymphoma. Blood 102:4059\u20134066","journal-title":"Blood"},{"key":"1698_CR45","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.1038\/onc.2010.111","volume":"29","author":"G Yin","year":"2010","unstructured":"Yin G, Chen R, Alvero AB, Fu HH, Holmberg J, Glackin C, Rutherford T, Mor G (2010) TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2\/214. Oncogene 29:3545\u20133553","journal-title":"Oncogene"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-016-1698-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-016-1698-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-016-1698-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T02:25:58Z","timestamp":1718850358000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-016-1698-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,20]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["1698"],"URL":"https:\/\/doi.org\/10.1007\/s00403-016-1698-8","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,20]]},"assertion":[{"value":"17 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Helene Sicard is employed by Innate Pharma, Marseille, France. The authors state no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}